Zio
iRhythm is a digital healthcare company focused on redefining cardiac arrhythmia diagnosis through its wearable biosensing technology, cloud-based data analytics, and machine learning. The company's primary product, Zio, is a complete ambulatory cardiac monitoring solution designed for patient comfort and clinical accuracy. Zio XT is recommended by NICE for detecting cardiac arrhythmias. iRhythm aims to be the leading provider of first-line ambulatory ECG monitoring, offering a platform that enables faster and more efficient diagnosis compared to traditional methods, ultimately leading to appropriate medical intervention and potentially preventing serious health events like stroke. The company has analyzed over 3 million patients and has a patient compliance rate of 98%.
Zio
iRhythm is a digital healthcare company focused on redefining cardiac arrhythmia diagnosis through its wearable biosensing technology, cloud-based data analytics, and machine learning. The company's primary product, Zio, is a complete ambulatory cardiac monitoring solution designed for patient comfort and clinical accuracy. Zio XT is recommended by NICE for detecting cardiac arrhythmias. iRhythm aims to be the leading provider of first-line ambulatory ECG monitoring, offering a platform that enables faster and more efficient diagnosis compared to traditional methods, ultimately leading to appropriate medical intervention and potentially preventing serious health events like stroke. The company has analyzed over 3 million patients and has a patient compliance rate of 98%.